.

Name : Ms. BHAWNA

Lab No. : 180665077 Age : 25 Years
Ref By : DR NISHA GUPTA Gender : Female
Collected : 16/10/2024 10:15:00AM Reported : 18/10/2024 4:41:24PM
A/c Status : P Report Status : Final
Collected at : PSC DAYALPUR Processed at : LPL-PREET VIHAR
B-1, MAIN KARAWAL NAGAR ROAD, NEHRU VIHA Plot no. 33, Defence Enclave, Vikas Marg,
R Preet Vihar, New Delhi-110092
DELHI

Test Report

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA 71.00 mg/dL 70 - 100

(Hexokinase)

*180665077* Page 1 of 5
.

Name : Ms. BHAWNA

Lab No. : 180665077 Age : 25 Years
Ref By : DR NISHA GUPTA Gender : Female
Collected : 16/10/2024 10:15:00AM Reported : 18/10/2024 4:41:24PM
A/c Status : P Report Status : Final

Collected at : PSC DAYALPUR Processed at : LPL-PREET VIHAR

B-1, MAIN KARAWAL NAGAR ROAD, NEHRU VIHA Plot no. 33, Defence Enclave, Vikas Marg,
R Preet Vihar, New Delhi-110092
DELHI

Test Report

CULTURE, URINE
(Conventional culture, Automated-MIC, KBDD)
Type of Specimen :

Dr. Raghav Chohda Dr.Sneha Kumari

MD Microbiology DNB, Pathology
Consultant Microbiologist Chief of Laboratory
Dr Lal PathLabs Ltd Dr Lal PathLabs Ltd

-------------------------------End of report --------------------------------

AHEEEHAPMKHIEKANLGHMJLPCBILLJCECCLKCIKPJNKEDFEFAPPAHEEEHA
BNFFFNBPAPBOAKNGFGELMGIPAOAHFHALBOJOBCJOFLELNOJGMPBNFFFNB
GMDACEFNJNOOCDCNHFIAAJHFJEDEHEDDNKPHENFLMKLMOEFLBLHDEHANP
DJCAIKFNBFGIELEIMIPELEPFAFHKALAFJIFFOBPAKKNJPDNLIDPBKEMEL
LAEGJLFIONFFDIAPAMIGMHBIAENJMDCHKKMHECEIPLKGKPNGKFFFOOIID
GBCBBEFDOECAMLFKIMJBHIPBADHFOFAINDFCBKDKBLIKOMNALNEJOOECD
LFIMIJFBILODAICIEOIPGFEHIHAFJBAKONOPBLMMMJCHKNFMIJNFIDILD
BNFNAMFMALNJIEKMAANHDLPILLBMFMBDOFCCAMNNIJKDKPNGBNFNAHILL
NKECDEFLLJEGFEIGPPPIHNBKHGAFEKFBJFFLBKOFOEBIOCNKDJPHNEKLJ
PNHAMCFCEPAJJDCKOJFOIDJBKDFKPNJHKEPBEBFLNKCKIGEOCMDKHKANK
BBIKNMFLGKKKNNAMPIMEAJEEINMNFAFBJNEEBFOFPNDMKPFKEPCIGKAMO
EGICGJFMMLDGBMIMHPCCLODEIEOPPFOEAMFPBLNOOLJAIANIPKONHDICL
MNNNNNEHKHBCLOMAGCFLHEBHJBAHFHANPKPFCMNLMKJIPFNPAHFHAHIKL
APBBBPAPBPHAEBFCPODKCIIFAHFCHHCAONFEPKPGOLMHNLNFEDFDGBKHH
HHHHHHHPHHPPHPPPPPHPPHPHHHPPPPPPPPPHHHHPPHHHPHPHHHHHPHPHP

IMPORTANT INSTRUCTIONS
ŸTest results released pertain to the specimen submitted .ŸAll test results are dependent on the quality of the sample received by the Laboratory .
ŸLaboratory investigations are only a tool to facilitate in arriving at a diagnosis and should be clinically correlated by the Referring Physician .ŸReport
delivery may be delayed due to unforeseen circumstances. Inconvenience is regretted .ŸCertain tests may require further testing at additional cost
for derivation of exact value. Kindly submit request within 72 hours post reporting.ŸTest results may show interlaboratory variations .ŸThe
Courts/Forum at Delhi shall have exclusive jurisdiction in all disputes /claims concerning the test(s) & or results of test(s).ŸTest results are not valid
for medico legal purposes.ŸThis is computer generated medical diagnostic report that has been validated by Authorized Medical Practitioner /Doctor.
The report does not need physical signature.
(#) Sample drawn from outside source.
If Test results are alarming or unexpected, client is advised to contact the Customer Care immediately for possible remedial action.
Tel: +91-11-49885050,Fax: - +91-11-2788-2134, E-mail: [email protected]

*180665077* Page 2 of 5
.

ANTIMICROBIAL SUSCEPTIBILITY TEST SAMPLE NO : 692173222

ACINETOBACTER SPECIES (>100000 colonies/ml grown)

AST
Antimicrobial Agent(Antibiotic) Tier MIC(ug/mL) Interpretation BMQ

Ceftazidime First 2 S 4

Ciprofloxacin First 4 R NA
Gentamicin First 16 R NA

Amikacin Second 4 S 4

Trimethoprim/ sulfamethoxazole Second 160 R NA

•S-SUSCEPTIBLE (Indicates clinically effective when used in standard therapeutic dose.)

•R-RESISTANT (Indicates clinically ineffective when used in standard or increased therapeutic dose.)

Breakpoint to MIC Quotient (BMQ) is calculated as susceptible breakpoint divided by MIC of the test isolate. Among the same line (spectrum) of antibiotics,
higher the BMQ better is the efficacy.

Page 1

Page 3 of 5
.

MIC GUIDING TABLE

INTRINSIC RESISTANCE
ACINETOBACTER SPECIES is intrinsically resistant to amoxicillin, amoxicillin clavulanate, ampicillin, azithromycin, aztreonam, cefazolin, cefotaxime,
cefoxitin, ceftriaxone, cefuroxime, cephalothin, chloramphenicol, clindamycin, daptomycin, doxycycline, ertapenem, erythromycin, fosfomycin (parenteral),
fusidic acid, linezolid, quinupristin/dalfopristin, teicoplanin, tetracycline, trimethoprim, vancomycin.

ANTIBIOTICS SPECIFIC COMMENT

As amikacin is nephrotoxic, kindly adjust the dosage according to the creatinine clearance.

INFECTION CONTROL ADVICE

Kindly ensure appropriate infection control measures along with contact precautions:

Strict hand hygiene ensure that the five moments of hand hygiene are followed

PPE: appropriate PPE such as gown and gloves while handling the patients

Patient placement in isolation room; if not available, cohorting can be followed by placing the patients with similar infection together in same cubicle or
corner of a ward

Ensure a spatial separation of 3 feet distance between beds with privacy curtain in-between

Single-use patient dedicated equipment such as BP cuffs, stethoscopes, nebulizer etc should be used

Patient transfer: infection control measures should be followed even during patient transfer
Page 2

Page 4 of 5
.

Page 3

Page 5 of 5